Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

STO/EXPRS2 stock hub

STO/EXPRS2 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

STO/EXPRS2is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

Nasdaq Stockholm

Market data

Price

Recent price action with selectable time range.

STO/EXPRS2STO/EXPRS2

—

Loading chart…

In the news

Latest news · STO/EXPRS2

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-88

P25 n/aP50 n/aP75 n/a

ROIC-63.4

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All STO/EXPRS2 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

176

Groups with data

Currency

SEK

Showing 176 of 176 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Sweden
Country code	SE
Employees	20
Employees Change	2%
Employees Change Percent	11.11
Enterprise value	SEK -39.2M
Exchange	Nasdaq Stockholm
Financial currency	SEK
First seen	2026-05-10
Industry	Biotechnology
Isin	SE0008348262
Last refreshed	2026-05-10
Market cap	SEK 7M
Price	SEK 2
Price currency	SEK
Rev Per Employee	542,600x
Sector	Healthcare
Sic	2836
Symbol	sto/EXPRS2
Website	https://www.expres2ionbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-641.39%
EV Earnings	0.87x
EV/FCF	0.83x
FCF yield	-668.54%
P/B ratio	0.21x
P/S ratio	0.65x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	55.64%
Gross Profit	SEK 6M
Gross Profit Growth	56.47%
Gross Profit Growth Q	6,460.98%
Gross Profit Growth3 Y	14.01%
Gross Profit Growth5 Y	-5.87%
Net Income	SEK -45.2M
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Pretax Margin	-493.31%
Profit Per Employee	SEK -2.3M
ROA	-40.44
Roa5y	-41.99
ROCE	-155.3
ROE	-88.02
Roe5y	-73.27
ROIC	-63.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-89.36%
Cagr3y	-78.3%
Cagr5y	-72.86%
EPS Growth Quarters	1
EPS Growth Years	3
Revenue Growth	36.83x
Revenue Growth Q	62.21x
Revenue Growth Years	1x
Revenue Growth3 Y	6.45x
Revenue Growth5 Y	-4.41x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	SEK 0.13
Assets	SEK 61.8M
Cash	SEK 36.9M
Current Assets	SEK 57.5M
Current Liabilities	SEK 28.3M
Debt	SEK 1.5M
Debt Equity	SEK 0.05
Debt FCF	SEK -0.03
Equity	SEK 33.3M
Interest Coverage	-117.2
Liabilities	SEK 28.5M
Long Term Assets	SEK 4.2M
Long Term Liabilities	SEK 213,000
Net Cash	SEK 35.4M
Net Cash By Market Cap	SEK 502
Net Cash Growth	-42.06%
Net Debt Equity	SEK -1.06
Tangible Book Value	SEK 31.6M
Tangible Book Value Per Share	SEK 11.9
WACC	17.7

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.98
Net Working Capital	SEK -9.8M
Quick ratio	1.96
Working Capital	SEK 26.5M
Working Capital Turnover	SEK 0.25

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-75.26%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-89.34%
200-day SMA	15.29
3Y total return	-98.98%
50-day SMA	4.96
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.85%
All Time High	2,760
All Time High Change	-99.93%
All Time High Date	2021-08-09
All Time Low	1.8
All Time Low Change	10.83%
All Time Low Date	2026-05-06
ATR	0.57
Beta	2.2
Beta1y	2.41
Beta2y	1.64
Ch YTD	-87.45
High	2.1
High52	34.2
High52 Date	2025-05-23
High52ch	-94.17%
Low	1.8
Low52	1.8
Low52 Date	2026-05-08
Low52ch	10.83%
Ma50ch	-59.75%
Price vs 200-day SMA	-86.95%
RSI	28.59
RSI Monthly	35.12
RSI Weekly	21.51
Sharpe ratio	-1.42x
Sortino ratio	-1.78
Total Return	-75.26%
Tr YTD	-87.45
Tr1m	-64.88%
Tr1w	1.79%
Tr3m	-87.11%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	SEK -53.8M
Operating margin	-495.7

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,381,181%
Net Borrowing	-497,000
Shares Insiders	4.22%
Shares Institutions	17.66%
Shares Out	3,530,233
Shares Qo Q	27.81%
Shares Yo Y	75.26%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	SEK -47.1M
Average Volume	52,626.35x
Bv Per Share	12.52
CAPEX	SEK -1,000
Ch1m	-64.88
Ch1w	1.79
Ch1y	-89.34
Ch3m	-87.11
Ch3y	-98.98
Ch5y	-99.86
Ch6m	-88.33
Change	7.55%
Change From Open	7.55
Close	1.86
Days Gap	0
Depreciation Amortization	1,518,000
Dollar Volume	92,015.4
Earnings Date	2026-05-05
EBIT	SEK -53.8M
EBITDA	SEK -52.3M
EPS	SEK -17.71
F Score	1
FCF	SEK -47.1M
FCF EV Yield	120.24x
FCF Per Share	SEK -13.34
Financing CF	9,147,000
Fiscal Year End	December
Founded	2,015
Income Tax	SEK -8.4M
Investing CF	43,000
Is Primary Listing	1
Last Earnings Date	2026-05-05
Last Report Date	2025-12-31
Last Split Date	2024-10-30
Last Split Type	Reverse
Ma150	12.92
Ma150ch	-84.56%
Ma20	2.57
Ma20ch	-22.43%
Net CF	-39,522,000
Next Earnings Date	2026-05-28
Open	1.86
Position In Range	65
Ppne	465,000
Price Date	2026-05-08
Ptbv Ratio	0.22
Relative Volume	0.86x
Revenue	10,852,000x
Tax By Revenue	-77.05x
Tr6m	-88.33%
Volume	46,123

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does STO/EXPRS2 pay a dividend?

Capital-return profile for this ticker.

Performance

STO/EXPRS2 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns STO/EXPRS2?

Insider, institutional, and short-interest positioning.

Institutional ownership

+17.7%

Share of float held by funds and institutions

Insider ownership

+4.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+75.3%

Negative means the company is buying back shares.

Technical

STO/EXPRS2 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

28.6

Below 30: short-term oversold

Price vs 200-day MA

-87.0%

50/200-day relationship not available

Beta (5Y)

2.20

More volatile than the market

Sharpe ratio

-1.42

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About STO/EXPRS2

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sto/EXPRS2 stock rating?

sto/EXPRS2 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sto/EXPRS2 analysis?

The full report lives at /stocks/sto/EXPRS2/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sto/EXPRS2?

The latest report frames sto/EXPRS2 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sto/EXPRS2 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.